Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.

Podrobná bibliografie
Hlavní autoři:	Pedersen-Bjergaard, J, Andersen, M, Christiansen, D, Nerlov, C
Médium:	Journal article
Jazyk:	English
Vydáno:	2002

TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
Autor: Ugo Testa, a další
Vydáno: (2023-06-01)

Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Autor: Milan Jagurinoski, a další
Vydáno: (2023-10-01)

Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report
Autor: Xian-Fu Sheng, a další
Vydáno: (2022-09-01)

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases
Autor: Yenny Alejandra Moreno Vanegas, a další
Vydáno: (2018-09-01)

Therapy-related leukemia and myelodysplasia: susceptibility and incidence
Autor: Giuseppe Leone, a další
Vydáno: (2007-10-01)

PB1823: SECONDARY ACUTE MYELOID LEUKEMIA AND DE NOVO ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES DISTINCT LANDSCAPE, OR THE SAME DISEASE?
Autor: M. Jagurinoski, a další
Vydáno: (2022-06-01)

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy
Autor: Harmony Leroy, a další
Vydáno: (2024-02-01)

ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype
Autor: Concepción Prats‐Martín, a další
Vydáno: (2020-06-01)

Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients
Autor: Lei Wang, a další
Vydáno: (2021-08-01)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
Autor: Craddock, C, a další
Vydáno: (2013)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
Autor: Craddock, C, a další
Vydáno: (2013)

Modeling CEBPA Mutant Acute Myeloid Leukemias
Autor: Nerlov, C
Vydáno: (2013)

Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia
Autor: Ruijuan Li, a další
Vydáno: (2016-06-01)

Acute abdominal pain due to atypical bilateral adrenal infarction in acute myeloid leukemia with alterations related to myelodysplasia: A case report
Autor: Risa Hirata, a další
Vydáno: (2023-10-01)

NFKB, TRAF6, AND MYDDOSOME GENE EXPRESSION IN MYELODYSPLASTIC NEOPLASM (SMD) AND ACUTE MYELOID LEUKEMIA MYELODYSPLASIA RELATED (AML-MR)
Autor: AA Vieira, a další
Vydáno: (2024-10-01)

Immunomodulatory Effect of Green Tea Treatment in Combination with Low-dose Chemotherapy in Elderly Acute Myeloid Leukemia Patients with Myelodysplasia-related Changes
Autor: Andrana K. Calgarotto, a další
Vydáno: (2021-03-01)

Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia
Autor: James N. Fisher, a další
Vydáno: (2020-07-01)

MYELODYSPLASIA-RELATED CYTOGENETIC ABNORMALITES IN CHILDHOOD ACUTE MYELOID LEUKEMIA – A 20-YEAR I-BFM- AML COLLABORATIVE DATABASE STUDY
Autor: Kristian Juul Sandahl, a další
Vydáno: (2023-12-01)

Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation
Autor: Daniele Avenoso, a další
Vydáno: (2021-11-01)

G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia
Autor: Karolien Beel, a další
Vydáno: (2009-10-01)

Myelodysplasia and acute myeloid leukemia fifteen years after high-dose cyclophosphamide in a child with severe aplastic anemia
Autor: José Carlos Jaime-Pérez, a další

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Autor: Ercole Brusamolino, a další
Vydáno: (2012-04-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Autor: Ercole Brusamolino, a další
Vydáno: (2014-08-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Autor: Ercole Brusamolino, a další
Vydáno: (2012-01-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Autor: Ercole Brusamolino, a další
Vydáno: (2014-08-01)

The −7 chromosomal abnormalities with signs of myelodysplasia in chronic myeloid leukemia as a major red signal
Autor: Emilie Cayssials, a další
Vydáno: (2019-06-01)

Myelodysplasia and Mast Cell Leukemia with t(9;22)
Autor: Kathryn J. Lago, a další
Vydáno: (2017-01-01)

Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia
Autor: Atoyebi, W, a další
Vydáno: (1997)

Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes
Autor: Matheus F. Bezerra, a další
Vydáno: (2022-07-01)

DISTINCTION BETWEEN ACUTE MYELOID LEUKAEMIA WITH MYELODYSPLASIA-RELATED CHANGES AND MIXED-PHENOTYPE ACUTE LEUKAEMIA: A DIAGNOSTIC CHALLENGE
Autor: NA Marcondes, a další
Vydáno: (2021-10-01)

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
Autor: Boultwood, J, a další
Vydáno: (1993)

INDUCTION OF A CDS+ T CELL RESPONSE TO THE MAGE CANCER TESTIS ANTIGEN BY COMBINED TREATMENT WITH AZACITIDINE AND SODIUM VALPROATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASIA
Autor: Goodyear, O, a další
Vydáno: (2010)

FACTORS DETERMINING CLINICAL RESPONSE TO 5 '-AZACITDINE AND SODIUM VALPROATE COMBINATION THERAPY IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA
Autor: Craddock, C, a další
Vydáno: (2010)

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
Autor: John F. Seymour, a další
Vydáno: (2017-12-01)

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia.
Autor: Goodyear, O, a další
Vydáno: (2010)

Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial
Autor: Craddock, C, a další
Vydáno: (2016)

Chromosomal deletions in myelodysplasia.
Autor: Boultwood, J, a další
Vydáno: (1995)

ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia
Autor: Charlotte Hellmich, a další
Vydáno: (2020-10-01)

Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities.
Autor: Dennis, M, a další
Vydáno: (2013)

P494: A FIRST-IN-HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK-MYELODYSPLASIA
Autor: Anthony Selwyn Stein, a další
Vydáno: (2023-08-01)

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.

Podobné jednotky

Podobné jednotky